2μm激光治疗膀胱移行细胞癌46例临床研究

2 μm laser treatment of bladder transitional cell carcinoma of the clinical study of 46 cases

目的:研究2μm激光汽化切除膀胱移位移行细胞癌(BTCC),是为寻找对BTCC手术切除的新方法。方法:66例BTCC患者住院后,46例采用Revolix2μm激光于骶管麻醉或表面麻醉下行经尿道汽化切除,20例采用开放手术治疗(术后放置导尿管至少5d)。用0.9%氯化钠溶液+丝裂霉素灌注清洗,开放组加切口周围清洗。结果:两组BTCC患者手术时间、出血量、住院天数、术中术后并发症比较,P<0.05,差异有统计学意义。结论:2μm激光汽化切除BTCC是一种操作方法简单,易掌握,术中安全,手术时间短,出血量少,缩短住院时间,并发症及复发率少的新技术。

Objective：To study the 2 μm laser ablation of transitional cell carcinoma of urinary bladder displacement （BTCC）,was looking for new ways BTCC surgery.Methods：66 patients with 46 cases of hospitalization BTCC Revolix 2 μm lasers with caudal anesthesia or topical anesthesia in transurethral vaporization resection,20 cases with open surgery（after catheter placed at least 5 days）.With 0.9% sodium chloride solution＋mitomycin infusion clean,open group of slabs around the mouth clean.Results：Both ETCC patients＇ operation time,blood loss,hospital stay,postoperative complications compared,P0.05,significant difference.Conclusion：2 μm laser ablation of BTCC is the kind of operation is simple and easy,safe technique,short operation time,less blood loss,shorter hospital stay,fewer complications and recurrence rate of new technology.